Has myelin basic protein received a fair trial in the treatment of multiple sclerosis?-Reference-Cited by-同舟云学术

Has myelin basic protein received a fair trial in the treatment of multiple sclerosis?

Published:1979-12 Issue:6 Volume:6 Page:461-468
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Alvord Ellsworth C.,Shaw Cheng-Mei,Hruby Sarka,Kies Marian W.

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference131 articles.

1. Effect of a synthetic polypeptide (Cop 1) on patients with multiple sclerosis and with acute disseminated encephalomyelitis

2. The onset and progression of the lesion in multiple sclerosis

3. : A comparison of the morphology of the human demyelinating diseases and experimental ?allergic? encephaloyelitis, in (eds): ?Allergic? Encephalomyelitis. Springfield, II Thomas, 1959, chap 5, pp 183-209

4. PATHOGENESIS OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: INTRODUCTORY REMARKS*

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapies for Multiple Sclerosis;From Basic Immunology to Immune-Mediated Demyelination;1999

2. Approaches to the treatment of central nervous system autoimmune disease using specific neuroantigen;Immunology and Cell Biology;1998-02

3. Protection against generalized autoimmunity of the nervous system (GANS), a novel animal model with combined features of EAE, EAN and EAU by a recombinant HIV-1 Tat37–72 peptide-based multiple T cell epitope vaccine;FEMS Immunology and Medical Microbiology;1997-03

4. Protection against generalized autoimmunity of the nervous system (GANS), a novel animal model with combined features of EAE, EAN and EAU by a recombinant HIV-1 Tat37–72peptide-based multiple T cell epitope vaccine;FEMS Immunology & Medical Microbiology;1997-03

5. Protection against experimental nervous system autoimmune diseases by a human immunodeficiency virus-1 Tat peptide-based polyvalent vaccine;Journal of Neuroscience Research;1996-10-15